David Dingli, MD, PhD

devoted to patients with plasma cell disorders and chronic myeloid leukemia. He completed his Residency and Fellowship from Mayo Clinic College of Medicine. Dr. David Dingli pursued his PhD in molecular biology from Mayo Clinic College of Medicine and Science.
Dr. Dingli has experience in treating conditions like amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, paroxysmal nocturnal hemoglobinuria, plasma cell disorders, POEMS syndrome, Schnitzler syndrome, and Waldenstrom macroglobulinemia.
Representative Publications:
Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis
Primary systemic amyloidosis in patients with Waldenström macroglobulinemia
Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method
Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma 
Natural history of multiple myeloma with de novo del(17p) 
In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution